image
Alkermes plc ALKS
Healthcare - Biotechnology - NASDAQ - IE
Watchlist
$ 34.775
1.3 %
$ 5.65 B
Market Cap
15.81
P/E
INCOME STATEMENT
1.56 B REVENUE
-6.36%
Growth Rates
1Year -6.36%
3Years 9.89%
5Years 5.87%
7Years 8.09%
10Years 9.67%
421 M OPERATING INCOME
1.57%
Growth Rates
1Year 1.57%
3Years 160.99%
5Years 35.66%
7Years 25.28%
10Years 21.18%
367 M NET INCOME
3.18%
Growth Rates
1Year 3.18%
3Years 112.68%
5Years 31.06%
7Years 23.27%
10Years 30.40%
EFFICIENCY
Earnings Waterfall Alkermes plc
image
Revenue 1.56 B
Cost Of Revenue 245 M
Gross Profit 1.31 B
Operating Expenses 892 M
Operating Income 421 M
Other Expenses 53.6 M
Net Income 367 M

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Mar-2013 Mar-2012 Mar-2011 Mar-2010 Mar-2009 Mar-2008 Mar-2007 Mar-2006 Mar-2005 Mar-2004 Mar-2003 Mar-2002 Mar-2001 Mar-2000 Mar-1999 Mar-1998 Mar-1997 Mar-1996 Mar-1995 Mar-1994 Mar-1993 Mar-1992
REVENUE
Revenue 1 557.6 1 663.4 1 111.8 1 173.8 1 038.8 1 170.9 1 094.3 903.4 745.7 628.3 618.8 575.5 390.0 186.6 178.3 326.8 240.7 240.0 166.6 76.1 39.1 47.3 54.1 56.0 22.9 43.7 31.3 19.8 14.0 12.3 7.8 9.5 1.7
GROSS PROFIT
Cost Of Revenue 245.3 253.0 218.1 603.9 572.9 693.2 601.8 567.6 519.3 483.4 447.9 310.5 127.6 52.2 49.4 43.4 40.7 45.2 23.5 16.8 19.0 10.9 0 0 0 0 0 0 (2.4) (2.2) (2.8) 15.2 6.4
Gross Profit 1 312.3 1 410.4 893.7 569.8 465.9 477.7 492.4 335.7 226.4 144.9 170.9 265.1 262.4 134.5 128.8 283.4 200.0 194.8 143.1 59.3 20.0 36.4 54.1 56.0 22.9 43.7 31.3 19.8 16.4 14.5 10.6 (5.7) (4.7)
OPERATING INCOME
Operating Expenses 891.7 996.2 1 036.0 599.1 578.3 639.8 591.6 483.6 435.1 369.2 258.1 167.6 350.7 180.1 171.9 148.5 196.4 183.7 129.5 119.9 117.1 112.1 116.5 85.9 98.9 79.3 39.5 37.2 30.3 26.3 29.2 36.6 3.3
Selling, General and Administrative Expenses 645.2 689.8 605.7 561.0 538.8 599.4 526.4 421.6 374.1 311.6 199.9 125.8 137.6 82.8 76.5 59.0 59.5 66.4 40.4 28.8 26.0 26.7 24.4 17.2 44.4 30.8 8.1 7.7 6.3 5.1 5.9 35.1 2.7
Research and Development Expenses 245.3 270.8 393.8 1.0 1.9 52.8 68.9 7.2 2.3 4.0 7.8 6.5 141.9 97.2 95.4 89.5 125.3 117.3 89.1 91.1 91.1 85.4 92.1 68.8 54.5 48.5 31.3 29.6 21.6 19.0 20.5 0 0
Operating Income 420.6 414.1 (142.3) (26.7) (112.4) (162.1) (99.1) (147.9) (208.7) (224.3) (87.1) 81.8 (88.3) (45.6) (43.0) 135.0 (2.8) 11.0 13.7 (72.1) (96.9) (82.2) (62.4) (29.9) (75.9) (38.8) (8.1) (17.4) (13.9) (11.8) (18.6) (42.3) (8.0)
PRE-TAX INCOME
Interest Income Expense 22.6 23.0 13.0 11.2 8.7 13.6 15.4 12.0 14.9 13.2 13.4 49.0 28.1 3.3 6.0 13.8 13.8 0.5 3.8 0 0 31.2 0 0 0 0 0 0 0 0 0 0 0
Total Other Income 23.1 7.4 (25.0) (137.1) 15.9 (21.6) (27.8) 4.6 (5.7) 0.3 73.1 1.0 (46.4) (68.8) (0.9) (1.7) (3.9) 175.6 (0.5) (9.8) (1.8) (5.3) (44.5) 1.0 13.0 34.9 35.6 11.0 1.1 0.5 11.8 18.6 34.2
Pre-Tax Income 443.8 421.5 (167.3) (39.3) (96.5) (197.1) (127.0) (143.3) (214.4) (224.0) (14.0) 35.4 (114.4) (46.5) (44.7) 131.0 172.8 10.5 3.8 (73.9) (102.4) (106.9) (61.4) (16.9) (68.0) (41.1) (9.8) (18.8) (13.7) (11.9) (17.3) (40.1) (8.1)
NET INCOME
Tax Provision 71.6 (97.6) (9.0) 8.9 14.3 (0.4) 12.3 14.7 (5.9) 3.2 16.0 10.5 (0.7) (1.0) (5.1) 0.5 5.9 1.1 (3.8) 73.9 102.4 31.2 (1.0) (13.0) 68.0 41.1 9.8 18.8 13.7 11.9 17.3 40.1 8.1
Net Income 367.1 355.8 (158.3) (48.2) (110.9) (196.6) (139.3) (157.9) (208.4) (227.2) (30.1) 25.0 (113.7) (45.5) (39.6) 130.5 167.0 9.4 3.8 (73.9) (102.4) (106.9) (61.4) (16.9) (68.0) (41.1) (9.8) (18.8) (13.7) (11.9) (17.3) (40.1) (8.1)
EPS 2.22 2.14 0.97 0.3 0.7 1.25 0.9 1.03 1.38 1.52 0.21 0.19 0.99 0.48 0.42 1.37 1.66 0.0952 0.0419 0.82 1.25 1.66 0.96 0.3 1.33 0.84 0.21 0.51 0.46 0.44 0.65 1.89 0.49